EUVIMEDEUVIMED entdecken
Crossref

Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells

Chezian Somasundaram, Karuna Sundarapandiyan, Tibor Keler, Yashwant M. Deo, Robert F. Graziano

Human Antibodies · 01.04.1999 · 9 (1) · 47-54

DOI: 10.3233/hab-1999-9105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Antibodies, erschienen am 01.04.1999. Verfasst von Chezian Somasundaram und 4 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Somasundaram, C., Sundarapandiyan, K., Keler, T., Deo, Y. M., & Graziano, R. F. (1999). Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells. Human Antibodies, 9(1), 47-54. https://doi.org/10.3233/hab-1999-9105

Vancouver

Somasundaram C, Sundarapandiyan K, Keler T, Deo YM, Graziano RF. Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells. Human Antibodies. 1999;9(1):47-54. doi:10.3233/hab-1999-9105

BibTeX
@article{Somasundaram1999,
  author = {Somasundaram, Chezian and Sundarapandiyan, Karuna and Keler, Tibor and Deo, Yashwant M. and Graziano, Robert F.},
  title = {Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells},
  journal = {Human Antibodies},
  year = {1999},
  volume = {9},
  number = {1},
  pages = {47--54},
  doi = {10.3233/hab-1999-9105}
}
Kostenlos starten →